Eli Lilly CEO Critiques Trump Trade Policies, Tariffs

Eli Lilly CEO Dave Ricks is joining a growing number of pharma chiefs calling for tax reform, not tariffs, to bolster U.S. investments.


Comment
Show comments Hide Comments


Related Articles